Health
Tocilizumab cuts mortality risk in severely ill COVID-19 patients finds new trial conducted in India – Medical Xpress
Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial…
Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial conducted in hospitals across Indiaone of the world’s most ethnically diverse countries. Researchers from the University of Bristol and Medanta Institute of Education and Research in India who led the study, published in The Lancet Respiratory Medicine, say it adds to existing evidence supporting the drug’s use in critically ill patients.
…
-
Business18 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News18 hours agoYoung voices shape Sunshine Coast’s future
-
Noosa News15 hours agoSudden death investigation, Maroochydore – Sunshine Coast
-
General22 hours agoUS stocks sink further as Donald Trump urges Americans to be ‘courageous and patient’